ArticleActa neuropathologica2024

Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors.

Jelena Jotanovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.